Back to Stocks
Rank #1694VCYT
Veracyte, Inc.
$36.28
-0.90% (Daily)
Market Cap
$2.87B
Revenue
$495.14M
Rank by MCap
#1694
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. Marc A. Stapley
Headquarters
South San Francisco, CA
Employees
824
About Veracyte, Inc.
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The compa...
Veracyte, Inc. Price Chart
Loading chart…